A Summary of the Updated Criteria for Alzheimer's Disease Alzheimer's disease (AD) is a progressive neurodegenerative disease that impacts memory, language, and other cognitive processes, with the prevalence of AD in the United States projected to increase to approximately 13.8 million by 2050. With the anticipated increase in AD cases and medical scientific advances, there was a need to ... Article
Article  |   December 14, 2016
A Summary of the Updated Criteria for Alzheimer's Disease
Author Affiliations & Notes
  • Sameer Ashaie
    Speech-Language-Hearing Sciences, CUNY Graduate Center, New York City, NY
  • Marta Korytkowska
    Speech-Language-Hearing Sciences, CUNY Graduate Center, New York City, NY
  • Disclosures
    Disclosures ×
  • Financial: Sameer Ashaie has no relevant financial interests to disclose. Marta Korytkowska has no relevant financial interests to disclose.
    Financial: Sameer Ashaie has no relevant financial interests to disclose. Marta Korytkowska has no relevant financial interests to disclose.×
  • Nonfinancial: Sameer Ashaie has no relevant nonfinancial interests to disclose. Marta Korytkowska has no relevant nonfinancial interests to disclose.
    Nonfinancial: Sameer Ashaie has no relevant nonfinancial interests to disclose. Marta Korytkowska has no relevant nonfinancial interests to disclose.×
Article Information
Special Populations / Older Adults & Aging / Attention, Memory & Executive Functions / Part 3
Article   |   December 14, 2016
A Summary of the Updated Criteria for Alzheimer's Disease
Perspectives of the ASHA Special Interest Groups, December 2016, Vol. 1, 117-121. doi:10.1044/persp1.SIG2.117
History: Received August 31, 2016 , Revised September 20, 2016 , Accepted September 25, 2016
Perspectives of the ASHA Special Interest Groups, December 2016, Vol. 1, 117-121. doi:10.1044/persp1.SIG2.117
History: Received August 31, 2016; Revised September 20, 2016; Accepted September 25, 2016

Alzheimer's disease (AD) is a progressive neurodegenerative disease that impacts memory, language, and other cognitive processes, with the prevalence of AD in the United States projected to increase to approximately 13.8 million by 2050. With the anticipated increase in AD cases and medical scientific advances, there was a need to update clinical diagnostic criteria that were established in the 20th century. The purpose of this article is to review the updated diagnostic standards to provide a framework for SLP's working with this population.

Order a Subscription
Pay Per View
All Perspectives articles & archives
24-hour access
This Article
24-hour access
We've Changed Our Publication Model...
The 19 individual SIG Perspectives publications have been relaunched as the new, all-in-one Perspectives of the ASHA Special Interest Groups.